Dispensing Evaluation of New Daily Disposable Toric Soft Contact Lens.
Recruiting in Palo Alto (17 mi)
+4 other locations
Age: 18 - 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Johnson & Johnson Vision Care, Inc.
No Placebo Group
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine the relative performance of a new daily disposable toric soft contact lens against a daily disposable toric contact lens currently available in market, specifically with regards to the comfort and vision with the lens.
Research Team
Eligibility Criteria
Inclusion Criteria
The subject's refractive cylinder axis must be 180 degrees plus or minus 30 degrees in each eye.
The subject must be an adapted wearer of soft toric contact lenses in both eyes.
The subject's best visual acuity (BVA) must be better than or equal to 20/25 in each eye.
See 7 more
Treatment Details
Interventions
- Etafilcon A toric contact lens (Soft Contact Lens)
- Nelfilcon A toric contact lens (Soft Contact Lens)
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Nelfilcon A toric/ Etafilcon A toricExperimental Treatment2 Interventions
Nelfilcon A toric contact lens first, then etafilcon A toric toric second
Group II: Etafilcon A toric contact lens/Nelfilcon A toricExperimental Treatment2 Interventions
Etafilcon A toric contact lens first, then nelfilcon A toric second
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johnson & Johnson Vision Care, Inc.
Lead Sponsor
Trials
224
Recruited
26,100+
Top Products
- ACUVUE® disposable contact lenses
- TECNIS® intraocular lenses
- LASIK vision correction systems
Joaquin Duato
Johnson & Johnson Vision Care, Inc.
Chief Executive Officer since 2022
Master’s from Thunderbird School of Global Management, MBA from ESADE
Dr. Raj Rajpal
Johnson & Johnson Vision Care, Inc.
Chief Medical Officer since 2023
MD